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glucose tolerance (2), reduces body fat, and increases oxygen consumption (3) (4) (5). The mechanism by which
CLA mediates any of these benefits is yet to be determined. However, Ip et al. (1) observed that an inhibitory
effect of CLA on mammary epithelial cell growth was
associated with apoptosis. This clue, coupled with the
observation that centrally administered leptin can cause
apoptosis of adipocytes (6), led us to test the hypothesis that dietary CLA causes apoptosis of adipocytes. We
also determined effects of dietary CLA in lines of mice
that differed genetically with regard to obesity.

Abstract
Objective: The objective of the study was to determine if consumption of conjugated linoleic acid (CLA) by mice could
induce apoptosis in adipose tissue. Other objectives were
to determine the influence of feeding mice CLA for ≤2
weeks on body fat, energy expenditure, and feed intake.
Research Methods and Procedures: A mixture of CLA isomers
(predominantly c9,t11 and t10,c12) was included in the
AIN-93G diet at 0, 1, and 2%, and fed to mice for 12 days
(Trial 1), or was included at 2% and fed to mice for 0, 5,
and 14 days (Trial 2). Feed intake was measured daily and
energy expenditure was determined by direct calorimetry
on day 9 in Trial 1. Retroperitoneal fat pads were analyzed
for apoptosis by determination of DNA fragmentation.
Results: Dietary CLA reduced feed intake by 10% to 12% (p <
0.01), but either did not influence or did not increase energy expenditure as indicated by heat loss. Body weight
was not influenced by consumption of CLA in Trial 1 but
was increased (p < 0.01) by CLA in Trial 2. Weights of retroperitoneal, epididymal, and brown adipose tissues were
lower (p < 0.01) in animals fed CLA, although liver weight
was increased (p < 0.10; Trial 1) or not changed (Trial 2).
Analysis of retroperitoneal fat pad DNA from both trials
indicated that apoptosis was increased (p < 0.01) by CLA
consumption.
Discussion: These results are interpreted to indicate that CLA
consumption causes apoptosis in white adipose tissue.
This effect occurs within 5 days of consuming a diet that
contains CLA.

Research Methods and Procedures
Materials
Male MH (12 weeks of age; n = 30), ML (12 weeks of age;
n = 30), C57BL/6J (10 weeks of age; n = 30) and M16 (retired breeders 26 to 30 weeks of age; n = 20) were obtained from our colony. The MH and ML mice were
generated by selection for high and low heat loss, respectively (7) (8). The MH mice emit 60% more heat than
ML mice, are leaner, and consume more feed. However,
MH and ML mice are not different in body weight at
any age up to at least 16 weeks. The M16 mice were generated by selection for maximum body weight gain during 3 to 6 weeks of age (9). These mice exhibit obesity
relative to unselected controls (10). The C57BL/6J mice
from our colony are from the Jackson Laboratories colony (Bar Harbor, ME). The C57BL/6J mice are similar
to ML mice with regard to low heat loss and feed intake
but similar to MH mice with regard to low body fatness. The growth rate of this inbred strain is slower than
that of the other strains used in this study (11). Animal
procedures were conducted as approved by the Uni-
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Introduction
Several prominent health benefits have been attributed
to consumption of conjugated linoleic acid (CLA). In rodents, dietary CLA stops cancer growth (1), improves
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Figure 1. Heat loss, Trial 1. In the fasted state, genetic line (p < 0.01) and genetic line by CLA interaction (p < 0.02) are significant,
but CLA is not (p > 0.5). In the refed state, line is significant (p < 0.01); CLA (p = 0.13) and line by CLA interaction (p > 0.5) are not
significant. SEM was 22 and 18 for fasted and refed states, respectively.

versity of Nebraska Institutional Animal Care and Use
Committee.
CLA (95% conjugated diene) was purchased from
Nu-Chek-Prep (Elysian, MN) and mixed into a purified
base diet (AIN-93G) by Dyets, Inc. (Bethlehem, PA). Soy
oil was replaced with CLA (1:1, w/w) to create the following diets: 1) 0% CLA, 7% soy oil; 2) 1% CLA, 6% soy
oil; and 3) 2% CLA, 5% soy oil. The CLA is reported by
the manufacturer to be 44% t10,c12; 10% c10,c12; 41%
c9,t11/t9,c11; and 5% other isomers.
Protocol
The experiment was composed of two trials. In Trial 1,
MH, ML, and C57BL/6J mice were housed individually
at 22 °C, under a photoperiod of 12 hours light and 12
hours dark (lights out at 7:00 PM), and fed AIN-93G diet
for 1 week before data collection. Mice were randomly
assigned to one of the three experimental diets that were
fed for 12 days. There were 10 replications of the nine
diet-by-line combinations. Experimental diets were fed
to the nine mice of the first replicate on day 1 of the
study. On day 2, the second replicate started to consume
the experimental diet and so forth, so that by day 10 all
90 animals were consuming the experimental diet.
Direct calorimetry was used to measure heat loss
during a 4-hour period beginning at 5:00 PM on day 9
for each replicate. A detailed description of our calorimetry method has been published elsewhere (7). Briefly,
the mice were placed individually into direct calorimeters (Thermonetics Corp., San Diego, CA), which mea-

sure voltage change that results from movement of heat
energy through the walls of the calorimeters. On the day
of calorimetry, feed was unavailable from 12:00 AM until 7:00 PM. Thus, heat loss was determined in the fasted
and in the refed state for each animal. Heat loss was determined at 1-minute intervals for 2 hours in each state.
Water was not available in the calorimeter chambers.
Three days after calorimetry, between 8:00 AM and
10:00 AM, mice were killed by CO2 asphyxia. Livers,
brown epididymal, and retroperitoneal fat pads were removed and weighed. The liver and brown fat pad from
each mouse were further analyzed for lipid content by
extraction with chloroform:methanol (2:1, v/v) and
0.05% sulfuric acid (12). Retroperitoneal fat pads from
animals fed 2% CLA (n = 12) and from animals fed the
control diet (n = 9) were frozen in liquid nitrogen and
stored (-80 °C) until being analyzed for apoptosis.
In Trial 2, 20 M16 mice were randomly allocated to
three treatments and fed either 0% CLA for 14 days (n =
7), 0% CLA for 9 days and then 2% CLA for 5 days (n =
6), or 2% CLA for 14 days (n = 7). Body weight change
was recorded and tissues were weighed and assayed for
apoptosis as in Trial 1.
Apoptosis Assays
Apoptosis assay was based on internucleosomal DNA
degradation (6). Retroperitoneal fat pads were homogenized in digestion buffer (100 mM NaCl, 10 mM tris(
hydroxymethyl)aminomethane-HCl [pH 8.0], 25 mM
EDTA, 0.5% sodium dodecyl sulfate, and 0.2 mg/ml
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Table 1. Heat loss in fasted and refed mice as influenced by genetic line and dietary CLA expressed on a 24-hour basis either per
animal, per body weight (kg), or per exponent of body weight (kg75) in Trial 1.
Fasted
Main effect
Line
C57
ML
MH
SEM

Refed

Heat

Heat/BW

Heat/BW75

7.0
10.4
14.4
0.43
(p < 0.01)*

266
279
400
12.3
(p < 0.01)

107
123
174
5.2
(p < 0.01)

Heat

Heat/BW
366
360
456
10.3
(p < 0.01)

147
158
199
4.4
(p < 0.01)

11.0
317
137
12.9
378
10.7
320
136
13.7
408
10.0
308
131
12.9
396
0.43
12.3
5.2
0.39
10.3
(p > 0.2)
(p > 0.5)
(p > 0.5)
(p > 0.2)
(p = 0.13)
						
BW, body weight.
* Significance of main effect.

162
174
168
4.4
(p = 0.18)

CLA
0%
1%
2%
SEM

proteinase K), nuclei and cellular debris were removed
by centrifugation, and the supernatant was incubated
at 55 °C overnight. The supernatant was then extracted
once with phenol:chloroform:isoamyl alcohol (25:24:1)
and twice with chloroform/isoamyl alcohol and then
precipitated in ethanol. The DNA was resuspended in
tris(hydroxymethyl)aminomethane-EDTA buffer and
treated with 0.1 U of deoxyribonuclease-free ribonuclease. One microgram of normalized DNA was labeled
with [32P]deoxycytidine triphosphate using the Klenow
fragment of DNA polymerase I, extracted, separated
by agarose gel electrophoresis, and viewed by autoradiography for the laddering pattern that is characteristic of apoptosis. The intensity of signals for the fragment of high molecular weight and fragments of low
molecular weight in each sample were quantified by
image analysis. The percentage of the intensity for low
molecular weight fragments versus the high molecular
weight fragment was expressed as the degree of DNA
fragmentation.
Data Analyses
Heat loss (kilocalories per day) and feed intake (grams
per day) were analyzed based on animal, body weight
(kg), and exponent of body weight (kg75). The General
Linear Models procedure of Statistical Analysis System (13) was used to compute ANOVA. For heat loss,
the model included effects of CLA level, genetic line, genetic line by CLA interaction, and animal within CLA
level-genetic line class. Heat loss was analyzed separately for the fed state and for the fasted state. Feed in-

9.6
13.4
16.5
0.39
(p < 0.01)

Heat/BW75

take and body weight analyses included the mentioned
effects plus the effect of day. Mean squares for animal
within CLA level-genetic line class were used as denominator of the F test for CLA level, genetic line, and CLA
level by genetic line interaction effects. Tissue weights
and apoptosis were analyzed similarly except that the
model did not include animal, and the residual mean
squares were used to determine significance. Apoptosis data were transformed by raising to the one-third
power to meet the ANOVA assumption of homogeneous variance.
Table 2. Feed intake (grams per day) expressed either per animal, per body weight (kg), or per exponent of body weight
(kg75) in Trial 1.
Main effect
Line
C57
ML
MH
SEM
		
CLA
0%
1%
2%
SEM
		

Feed intake

Feed/BW

Feed/BW75

4.2
4.5
5.5
0.11
(p < 0.01)*

159
121
153
3.7
(p < 0.01)

64
53
66
1.5
(p < 0.01)

5.0
4.7
4.4
0.11
(p < 0.01)

153
144
137
3.7
(p < 0.01)

65
61
58
1.5
(p < 0.01)

BW: body weight.
* Significance of main effect.
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Figure 3. Trial 2, weight of brown (BAT), epididymal (EPI),
retroperitoneal (RP), and subcutaneous (SC) fat pads and of
the liver (scaled to 10% of actual weight) and heart as influenced by 2% CLA fed for either 0, 5, or 14 days. *CLA effect (p
< 0.01). Error bars represent SEM.

Figure 2. Trial 1, weight of brown (BAT), epididymal (EPI),
and retroperitoneal (RP) fat pads and of the liver (scaled to
10% of actual weight) as influenced by line (top) and dietary
CLA (bottom). Genetic line affected all tissues (p < 0.01). **CLA
effect (p < 0.01). *CLA effect (p < 0.10). Genetic line by CLA interaction was not significant for all tissues (p > 0.5). Error bars
represent SEM.

Results and Discussion
Heat Loss and Feed Intake (Trial 1)
We expected that feeding mice CLA would stimulate
heat production because West et al. (4) had reported that
it increases oxygen consumption. Their mice consumed
feed ad libitum, so we used a similar protocol. Our heat
loss results are presented in Figure 1 and Table 1. Feed
intake results are presented in Table 2. Results in Tables
1 and 2 are presented based on animal, body weight, and
an exponential function of body weight commonly considered to be “metabolic body weight” (weight75), because there is some controversy as to which is appropriate, especially when comparing energy expenditure with
feed consumption (14). In fasted mice, regardless of denominator used for expressing the results, the genetic
line by CLA interaction indicated that CLA suppresses
heat loss in MH mice but stimulates heat loss in ML and
C57BL/6J mice (Figure 1; p < 0.05). The magnitude of
this interaction is small and its biological significance is

unclear. No such interaction was observed in refed mice.
CLA tended to increase heat production in refed mice (p
= 0.13), but only when expressed per body weight (Table 1). This effect (8% increase) is similar to the 12% increase in energy expenditure attributed to CLA by West
et al. (4). Perhaps the response we observed was less robust due to the shorter period of CLA consumption in
our experiment (9 days vs. 6 weeks). Altogether, the heat
loss results indicate that CLA caused either no change or
an increase in energy expenditure, while reducing feed
consumption. Feed intake was reduced 10.5% to 12% by
CLA (p < 0.01; Table 2) in all three lines. This is similar to
the 9.6% reported by West et al. (4). There was no interaction of genetic line and diet.
Body Weight (Trials 1 and 2)
Consumption of CLA, despite reducing feed intake, did
not cause a loss of body weight. During Trial 1, change
in body weight between day 1 and day 12 was 2.4, 1.5,
and 1.2 g for mice fed 0, 1%, and 2% CLA, respectively
(SEM = 0.63; p > 0.37). There was no genetic line-bydiet interaction effect on body weight. C57BL/6J mice
weighed less than MH or ML mice. This was partly because they were 2 weeks younger, but even at constant
age C57BL/6J mice weighed less than MH or ML mice
(11). In Trial 2, consumption of CLA had a positive effect on body weight. At the end of the 14-day period,
the body weight of mice fed CLA for 0, 5, and 14 days
changed -7.1, 1.6, and -0.6 g, respectively (SEM = 2.0; p
< 0.01).
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Figure 4. Apoptosis in retroperitoneal fat pads. Effect of CLA pooled across Trials 1 and 2 (p < 0.01). From left to right, bars represent data from 9, 12, 7, 6, and 7 animals. SE is 0.19.

Tissue Weights (Trials 1 and 2)
In Trial 1, brown, epididymal, and retroperitoneal fat
pad weights were each significantly reduced by dietary CLA (p < 0.01). Significant variation in each tissue weight was also accounted for by genetic line (p <
0.01), but there was no diet-by-genetic line interaction.
Therefore, only the main effects of diet and of line are
depicted in Figure 2. Consumption of CLA reduced the
weight of epididymal, retroperitoneal, and brown fat
pads. This could potentially be explained by an increase
in adipose tissue hormone-sensitive lipase activity combined with a reduction of lipoprotein lipase activity as
observed by Park et al. (3). These changes in enzyme activity would lead to a net loss of fatty acids from the tissue. Indeed, the brown fat pads of CLA-fed mice in Trial
1 contained less lipid. The lipid content of mice fed 0,
1%, and 2% CLA was 52%, 42%, and 42%, respectively
(SEM = 1.7; p < 0.01). If fatty acid oxidation was not concurrently stimulated, the circulation of fatty acid to the
liver and subsequent re-esterification could potentially
cause an increase in liver weight. Our CLA-fed mice in
Trial 1 tended to exhibit increased liver weight (7.6%; p <
0.10). West et al. (4) observed that feeding mice 1% CLA
for 6 weeks caused liver weight to increase by 22%. The
lipid content of livers from mice fed 0, 1%, and 2% CLA
was 10.7%, 11.4%, and 12.9%, respectively (SEM = 1.4%;
p > 0.5). Therefore, any increase in liver weight that may
have occurred in our mice due to CLA intake does not
appear to have resulted from lipid accumulation. Nevertheless, CLA intake dramatically reduced the weight
of fat pads. The relatively small reduction in feed intake
by CLA-fed mice during the 12 days probably does not
account for the fat loss. Others have argued this point
(3) (4), and in studies using mild feed restriction, we
have not observed changes in fat pad weight (our unpublished observations). Normally fat depletion due to

feed restriction is accompanied by a reduction in body
weight in mature animals; we did not observe such a reduction in this study.
In Trial 2, brown, epididymal, retroperitoneal, and
subcutaneous fat pads were all reduced in CLA-fed animals (p < 0.01; Figure 3). The effect of CLA was apparent after only 5 days of continuous consumption. The
weight of fat pads after 5 days of CLA intake was not
different (p > 0.10) from the weight of corresponding
pads on day 14. In contrast, heart and liver weights were
not affected by dietary CLA.
Apoptosis (Trials 1 and 2)
Apoptosis was increased in the retroperitoneal fat pads
of mice fed 2% CLA compared with those consuming
the control diet (Figure 4; p < 0.01). After either 5 or 14
days of CLA consumption, the incidence of apoptosis
was at least 4-fold greater than the incidence in control
mice. This apoptosis cannot be accounted for by the 10%
to 12% reduction in feed intake. Apoptosis was not observed after restricting feed intake by 60% (6). CLA has
been reported to cause apoptosis of mammary epithelial cells (1), and it reduces cell number in preadipocyte
cultures (15) (16). The latter effect has been attributed to
inhibition of proliferation and is not due to cytoxicity,
as indicated by low media lactate dehydrogenase activity and trypan blue exclusion. However, apoptosis was
not specifically assayed (16). We do not know whether
apoptosis can be detected by trypan blue exclusion but
assume that it does not cause release of intracellular enzymes. Our observation that CLA induces apoptosis
in adipose tissue is consistent with two recent reports.
First, dietary CLA caused apoptosis in mouse adipose
tissue (17). Second, addition of CLA caused apoptosis
in cultured 3T3-L1 cells (18). We conclude that dietary
CLA can cause apoptosis in mouse adipose tissue.
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Given the incidence of obesity among humans, the
fact that CLA selectively reduces body fat deposits (versus lean), and the incomplete understanding of how
CLA mediates this effect, the observation that CLA promotes apoptosis in adipose tissue warrants attention.
Acknowledgments
This project was supported by an Undergraduate Honors Research Grant awarded to C.A.C. by the University of Nebraska
Agricultural Research Division. The M16 strain mice were
kindly provided by Drs. E. Eisen and D. Pomp.

References
1. Ip, M. M., Masso-Welch, P. A., Shoemaker, S. F., Shea-Eaton,
W. K., Ip, C. (1999) Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250: 22–34.
2. Houseknecht, K. L., Vanden Heuvel, J. P., Moya-Camarena,
S. Y., et al. (1998) Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty
fa/fa rat. Biochem Biophys Res Commun 244: 678–682.
3. Park, Y., Albright, K. J., Liu, W., Storkson, J. M., Cook, M. E.,
Pariza, M. W. (1997) Effect of conjugated linoleic acid on
body composition in mice. Lipids 32: 853–858.
4. West, D. B., Delany, J. P., Camet, P. M., Blohm, F., Truett,
A. A., Scimeca, J. (1998) Effects of conjugated linoleic acid
on body fat and energy metabolism in the mouse. Am J
Physiol 275: R667–R672.
5. DeLany, J. P., Blohm, F., Truett, A. A., Scimeca, J. A., West,
D. B. (1999) Conjugated linoleic acid rapidly reduces body
fat content in mice without affecting energy intake. Am J
Physiol 276: R1172–R1179.
6. Qian, H., Azain, M. J., Compton, M. M., Hartzell, D. L.,
Hausman, G. J., Baile, C. A. (1998) Brain administration of
leptin causes deletion of adipocytes by apoptosis. Endocrinology 139: 791–794.
7. Nielsen, M. K., Jones, L. D., Freking, B. A., DeShazer, J. A.
(1997) Divergent selection for heat loss in mice: I. Selection

J. L. M i n e r

et al. in

O b e s i t y R e s e a r c h 9 (2001)

applied and direct response through fifteen generations. J
Anim Sci 75: 1461–1468.
8. Nielsen, M. K., Freking, B. A., Jones, L. D., Nelson, S. M.,
Vorderstrasse, T. L., Hussey, B. A. (1997) Divergent selection for heat loss in mice: II. Correlated responses in feed
intake, body mass, body composition, and number born
through fifteen generations. J Anim Sci 75: 1469–1476.
9. Eisen, E. J. (1975) Population size and selection intensity effects on long-term selection response in mice. Genetics 79:
305–323.
10. Eisen, E. J. (1987) Effects of selection for rapid postweaning
gain on maturing patterns of fat depots in mice. J Anim Sci
64: 133–147.
11. Moody, D. E., Pomp, D., Nielsen, M. K. (1997) Variability
in metabolic rate, feed intake, and fatness among selection
and inbred lines of mice. Genet Res 70: 225–235.
12. Folch, J., Lees, M., Sloan-Stanley, G. H. (1957) A simple
method for the isolation and purification of total lipids
from animal tissues. J Biol Chem 224: 497–509.
13. SAS Institute Inc (1991) SAS Language and Procedures:
Usage 2, Version 6. 1st ed, SAS Institute Inc Cary, NC
891–996.
14. Himms-Hagen, J. (1997) On raising energy expenditure in
ob/ob mice. Science 276: 1132–1133.
15. Brodie, A. E., Manning, V. A., Ferguson, K. R., Jewell, D.
E., Hu, C. Y. (1999) Conjugated linoleic acid inhibits differentiation of pre- and post-confluent 3T3–L1 preadipocytes
but inhibits cell proliferation only in preconfluent cells. J
Nutr 129: 602–606.
16. Satory, D. L., Smith, S. B. (1999) Conjugated linoleic acid
inhibits proliferation but stimulates lipid filling of murine
3T3–L1 preadipocytes. J Nutr 129: 92–97.
17. Tsuboyama-Kasaoka, N., Takahashi, M., Tanemura, K.,
et al. (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49: 1534–1542.
18. Evans, M., Geigerman, C., Cook, J., Curtis, L., Kuebler, B.,
McIntosh, M. (2000) Conjugated linoleic acid suppresses
triglyceride accumulation and induces apoptosis in 3T3–L1
preadipocytes. Lipids 35: 899–910.

